Urine is formed by the kidney and stored in the bladder. The bladder expands and contracts depending on how much urine is stored inside. Cancer can develop in the bladder as it does in other bodily organs. Most bladder cancer arises in the cells that line the bladder. The February 16, 2005, issue of JAMA includes an article about bladder cancer.
Blood in the urine
Frequent urination
Painful urination
Smoking greatly increases the chance of having bladder cancer. Smoking also increases the death rate from bladder cancer.
Older persons have a greater risk for bladder cancer than younger individuals.
Men develop bladder cancer 4 times more often than women.
Diagnosis and treatment of bladder cancer is usually done by a urologist (a doctor with specialized training in surgery of the urinary tract). Urine may be sent to the lab for analysis, cell count, or culture. Cystoscopy, passing a lighted tube into the bladder through the urethra (the tube that carries urine from the bladder to outside the body), may be performed to see the inner lining of the bladder and examine it for growths or tumors. Biopsies (small samples of tissue) may be taken to examine under a microscope. Other testing may include an intravenous pyelogram, an x-ray test using dye to look at the kidneys and ureters, the tubes that drain urine into the bladder from the kidneys. If more invasive bladder cancer is suspected, other tests may be done to determine if the cancer has spread to other areas.
Grahic Jump Location
Treatment usually includes transurethral (through the urethra) resection of the bladder tumor. This surgical procedure is done with the patient under anesthesia. More extensive surgery may be needed if the bladder tumor has invaded beyond the lining of the bladder. This may include cystectomy (removal of the bladder) with creation of a urine-draining system. Chemotherapy (use of anticancer medications), radiation (x-ray) therapy, and immunologic therapy may be used to treat advanced bladder cancer. Immunologic therapy uses biologic agents to help the body's own immune system fight the bladder cancer. Cancer clinical trials are an option for individuals who have advanced or recurrent bladder cancer that has been resistant to standard treatment.
American Cancer Society 800/227-2345 http://www.cancer.org
National Cancer Institute 800/422-6237 http://www.cancer.gov
American Foundation for Urologic Disease 800/828-7866 http://www.afud.org
To find this and previous JAMA Patient Pages, go to the Patient Page link on JAMA's Web site at http://www.jama.com. A Patient Page on cancer clinical trials was published in the June 9, 2004, issue; and one on kidney cancer was published in the July 7, 2004, issue.
Sources: American Cancer Society, National Cancer Institute, American Foundation for Urologic Disease
The JAMA Patient Page is a public service of JAMA. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA suggests that you consult your physician. This page may be photocopied noncommercially by physicians and other health care professionals to share with patients. Any other print or online reproduction is subject to AMA approval. To purchase bulk reprints, call 718/946-7424.
TOPIC: CANCER
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Journal of American Medical Association editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Customize your page view by dragging & repositioning the boxes below.
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.